Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
62.47 USD | -2.04% | -8.36% | +13.09% |
May. 16 | Ani Pharmaceuticals Insider Sold Shares Worth $1,101,821, According to a Recent SEC Filing | MT |
May. 10 | ANI Pharmaceuticals Seeks M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.09% | 1.24B | |
+32.11% | 694B | |
+29.39% | 593B | |
-1.69% | 371B | |
+20.03% | 331B | |
+6.90% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+7.94% | 169B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Guggenheim Adjusts ANI Pharmaceuticals' Price Target to $77 From $70, Maintains Buy Rating